PharmaShots Weekly Snapshot (February 24-28, 2020)
Published: Feb 28, 2020 | Tags: Companion Medical, InPen Diabetes Management System, Receives, US, FDA, Approval, Fixed Dosing, Meal Estimation
Published: Feb 28, 2020 | Tags: Takeda, Vedolizumab SC, Receives, CHMP, Positive Opinion, Maintenance Therapy, Moderately to Severely Active, UC, CD
Published: Feb 27, 2020 | Tags: Gates Foundation, Forms, Alliance, Global Pharma Companies, Develop, PAN-TB, Drug Regimen, Tuberculosis
Published: Feb 25, 2020 | Tags: Fujifilm, CAD EYE, Receives, CE Mark, Support, Detection, Colonic Polyp, Utilizing AI, EU
Published: Feb 27, 2020 | Tags: Boehringer Ingelheim, Collaborates, Trutino Biosciences, Develop, New Therapies, Utilizing,s On-Demand-Cytokine Platform
Published: Feb 27, 2020 | Tags: Biogen, Signs, Worldwide, License Agreement, Sangamo, Develop, Gene Therapies, Multiple Neurological Diseases
7. Co-Diagnostics Receives CE Mark for its Logix Smart Coronavirus PCR Test
Published: Feb 24, 2020 | Tags: Co-Diagnostics, Receives, CE Mark, Logix Smart Coronavirus PCR Test
Published: Feb 27, 2020 | Tags: GSK, Reports, Acceptance, EMA, MAA, Zejula, niraparib, 1L, Maintenance Treatment, Platinum-Responsive, Advanced Ovarian Cancer
9. Esperion Receives the US FDAs Approval for Nexlizet (Non-Statin LDL-Cholesterol Lowering Therapy)
Published: Feb 27, 2020 | Tags: Esperion, Receives, US, FDA, Approval, Nexlizet, Non-Statin, LDL-Cholesterol Lowering Therapy
Published: Feb 27, 2020 | Tags: Hikma, Signs, Exclusive, License Agreement, Glenmark, Commercialize, Ryaltris, olopatadine hydrochloride, mometasone furoate, nasal spray, US
Published: Feb 26, 2020 | Tags: Gemini Therapeutics, Signs, Research Agreement, SERI, Identify, New Therapies, Age-related Macular Degeneration
12. ?? Gilead Reports the Initiation of Two P-III Studies of Remdesivir to Treat COVID-19
Published: Feb 26, 2020 | Tags: Gilead, Reports, Initiation, Two, P-III, Studies, Remdesivir, Treat, COVID-19
Published: Feb 25, 2020 | Tags: Eisai, Signs, License Agreement, FUJI YAKUHIN, Dotinurad, Hyperuricemia, Gout, China
14. The US FDA Upgrades the Purple Book to Assist the Transparency in Biosimilars
Published: Feb 24, 2020 | Tags: US, FDA, Upgrades, Purple Book, Assist, Transparency, Biosimilars
15. Johnson & Johnson in Collaboration with Apple Launch Heartline Study App in the US
Published: Feb 25, 2020 | Tags: Johnson & Johnson, Collaboration, Apple, Launch, Heartline Study
16. Takeda Exercises its Exclusive Option to Acquire PvP Biologics for ~$330M
Published: Feb 26, 2020 | Tags: Takeda, Exercises, Exclusive, Option to Acquire, PvP Biologics, ~$330M
Published: Feb 25, 2020 | Tags: WuXi Biologics, Vir Biotechnology, Collaborate, Global Development, Antibodies, Against, COVID-19
18. Novartis Collaborates with DNDi to Develop LXE408 for Visceral Leishmaniasis
Published: Feb 25, 2020 | Tags: Novartis, Collaborates, DNDi, Develop, LXE408, Visceral Leishmaniasis
Published: Feb 25, 2020 | Tags: Genentech, Collaborates, Bicycle Therapeutics, Develop, Commercialize, Bicycle-Based Immuno-Oncology Therapies
Published: Feb 24, 2020 | Tags: FMCNA, Novalung, ECMO, Receives, US, FDA, Approval, Acute Respiratory, Cardiopulmonary Failure
Published: Feb 25, 2020 | Tags: Takeda, Alunbrig, brigatinib, Receives, US, FDA, Priority Review, ALK + Metastatic Non-Small Cell Lung Cancer
22. STADA Acquires GSKs Consumer Healthcare Portfolio to Expand its OTC Business
Published: Feb 24, 2020 | Tags: STADA, Acquires, GSK, Consumer Healthcare Portfolio, Expand, OTC, Business
23. AstraZeneca to Divest Global Rights of Movantik (naloxegol) to RedHill Biopharma
Published: Feb 25, 2020 | Tags: AstraZeneca, Divests, Global Rights, Movantik, naloxegol, RedHill Biopharma
Published: Feb 25, 2020 | Tags: Roche, Reports, Acceptance, BLA, Fixed-Dose SC Combination, Perjeta, Herceptin, HER2-Positive Breast Cancer
25. Sanofi to Establish New Company to Provide Active Pharmaceutical Ingredients in the EU
Published: Feb 25, 2020 | Tags: Sanofi, Establish, New Company, Provide, Active Pharmaceutical Ingredients, EU
26. GSK Signs a Research Collaboration with Clover for the Evaluation of Coronavirus (COVID-19) Vaccine
Published: Feb 24, 2020 | Tags: GSK, Signs, Research Collaboration, Clover, Evaluation, Coronavirus, COVID-19, Vaccine
27. Paratek Signs an Exclusive License Agreement with Almirall for SEYSARA (sarecycline)
Published: Feb 24, 2020 | Tags: Paratek, Signs, Exclusive, License Agreement, Almirall, SEYSARA, sarecycline
Published: Feb 10, 2020 | Tags: Asuragen, AmplideX, Fragile X Dx, Carrier Screen Kit, Receives, US, FDA, Approval, Detecting, Fragile X Syndrome, FXS
29. ? Lundbecks Vyepti (eptinezumab-jjmr) Receives the US FDAs Approval to Prevent Migraine in Adults
Published: Feb 22, 2020 | Tags: Lundbeck, Vyepti, eptinezumab-jjmr, Receives the US FDAs Approval to Prevent Migraine in Adults
30. Eli Lillys Trulicity (dulaglutide) Receives the US FDAs Approval to Reduce MACE in T2D Adults
Published: Feb 22, 2020 | Tags: Lundbeck, Vyepti, eptinezumab-jjmr, Receives the US FDAs Approval to Prevent Migraine in Adults
Published: Feb 21, 2020 | Tags: Eli Lilly, Trulicity, dulaglutide, Receives, US, FDA, Approval, Reduce, MACE, T2D, Adults
Published: Feb 24, 2020 | Tags: Novartis, reports, Acceptance, Ofatumumab, OMB157, sBLA, US, FDA, EMA, Treat, Relapsing, Form, Multiple Sclerosis, RMS
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com